Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis has released its monthly share capital and voting rights report as of December 31, 2024. The company reported a total of 100,093,873 shares in the capital and 88,660,539 voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority, as the company is listed on Euronext Growth under ISIN code FR0010425595.

News Market Reaction – CLLS

-4.15%

1 alert

-4.15% News Effect

On the day this news was published, CLLS declined 4.15%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
12/31/2024	100,093,873	88,660,539

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:       

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com

 

Attachment

• Voting_Rights_PR_December_2024_EN

FAQ

How many total shares does Cellectis (CLLS) have as of December 31, 2024?

As of December 31, 2024, Cellectis has 100,093,873 total shares in the capital.

What is the current number of voting rights for Cellectis (CLLS)?

Cellectis has 88,660,539 voting rights as of December 31, 2024.

On which exchange is Cellectis (CLLS) stock listed?

Cellectis is listed on Euronext Growth market.

What is the ISIN code for Cellectis (CLLS) shares?

The ISIN code for Cellectis shares is FR0010425595.